Detalhe da pesquisa
1.
Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.
PLoS Pathog
; 11(8): e1005110, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26267277
2.
Blimp-1, an intrinsic factor that represses HIV-1 proviral transcription in memory CD4+ T cells.
J Immunol
; 194(7): 3267-74, 2015 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-25710909
3.
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies.
Proc Natl Acad Sci U S A
; 109(47): E3268-77, 2012 Nov 20.
Artigo
Inglês
| MEDLINE | ID: mdl-23115339
4.
Absolute quantitation of binding antibodies from clinical samples.
NPJ Vaccines
; 9(1): 8, 2024 Jan 06.
Artigo
Inglês
| MEDLINE | ID: mdl-38184641
5.
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity.
Retrovirology
; 10: 102, 2013 Sep 23.
Artigo
Inglês
| MEDLINE | ID: mdl-24059682
6.
Longitudinal analysis of early HIV-1-specific neutralizing activity in an elite neutralizer and in five patients who developed cross-reactive neutralizing activity.
J Virol
; 86(4): 2045-55, 2012 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-22156522
7.
The development of CD4 binding site antibodies during HIV-1 infection.
J Virol
; 86(14): 7588-95, 2012 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-22573869
8.
Activity of broadly neutralizing antibodies, including PG9, PG16, and VRC01, against recently transmitted subtype B HIV-1 variants from early and late in the epidemic.
J Virol
; 85(14): 7236-45, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21561918
9.
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.
J Transl Med
; 10: 144, 2012 Jul 11.
Artigo
Inglês
| MEDLINE | ID: mdl-22784600
10.
Cross-reactive neutralizing humoral immunity does not protect from HIV type 1 disease progression.
J Infect Dis
; 201(7): 1045-53, 2010 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20170371
11.
HIV Antibody Fc N-Linked Glycosylation Is Associated with Viral Rebound.
Cell Rep
; 33(11): 108502, 2020 12 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33326789
12.
Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users.
Viruses
; 11(4)2019 04 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31027215
13.
Plasma CXCL13 but Not B Cell Frequencies in Acute HIV Infection Predicts Emergence of Cross-Neutralizing Antibodies.
Front Immunol
; 8: 1104, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28943879
14.
The Neutralizing Antibody Response in an Individual with Triple HIV-1 Infection Remains Directed at the First Infecting Subtype.
AIDS Res Hum Retroviruses
; 32(10-11): 1135-1142, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-26910384
15.
Exploring the potential of monoclonal antibody therapeutics for HIV-1 eradication.
AIDS Res Hum Retroviruses
; 31(1): 13-24, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25385703
16.
Early development of broadly reactive HIV-1 neutralizing activity in elite neutralizers.
AIDS
; 28(8): 1237-40, 2014 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-24556870
17.
Genome-wide association study on the development of cross-reactive neutralizing antibodies in HIV-1 infected individuals.
PLoS One
; 8(1): e54684, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23372753
18.
Cross-reactive broadly neutralizing antibodies: timing is everything.
Front Immunol
; 3: 215, 2012.
Artigo
Inglês
| MEDLINE | ID: mdl-22833745
19.
Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.
Clin Cancer Res
; 18(3): 882-9, 2012 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-22156611
20.
Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level.
Nat Med
; 16(9): 995-7, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-20802498